Sign Up to like & get
recommendations!
1
Published in 2022 at "Current molecular medicine"
DOI: 10.2174/1566524022666220113151044
Abstract: AIMS This study aimed to clarify that breviscapine combined with bone marrow mesenchymal stem cells (BMSCs) treatment can reduce Aβ deposition in Alzheimer's disease (AD) patients. BACKGROUND AD is a common degenerative disease of the…
read more here.
Keywords:
expression;
deposition;
breviscapine;
breviscapine combined ... See more keywords